CAMP
Camp4 Therapeutics Corp
Key Financials
Operating Income
$-52555000
↑ 1.0%
Net Income
$-80403000
↓ 55.2%
Revenue
$3.5M
↑ 436.5%
Cash & Equivalents
$109.5M
↑ 71.0%
EPS (Diluted)
$-2.65
↑ 76.0%
Shareholders' Equity
$47.7M
↓ 24.5%
Total Liabilities
$70.1M
↑ 362.3%
Total Assets
$117.8M
↑ 50.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| EFFECT | 8/12/2026 | View on SEC |
| 424B3 | 8/12/2026 | View on SEC |
| SCHEDULE 13G | 8/10/2026 | View on SEC |
| S-3 | 8/6/2026 | View on SEC |
| SCHEDULE 13D/A | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CAMP |
| Company Name | Camp4 Therapeutics Corp |
| CIK | 1736730 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-651-8867 |